Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Evolus Q2 2024 Adj. EPS $(0.04) Beats $(0.05) Estimate, Sales $66.909M Beat $65.784M Estimate

Author: Benzinga Newsdesk | July 31, 2024 05:53pm
Evolus (NASDAQ:EOLS) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.05) by 20 percent. The company reported quarterly sales of $66.909 million which beat the analyst consensus estimate of $65.784 million by 1.71 percent. This is a 35.59 percent increase over sales of $49.346 million the same period last year.

Posted In: EOLS


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist